Temsirolimus | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Temsirolimus
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Temsirolimus

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 5 USDMF, 2 EU WC, 2 NDC API, 6 Listed Suppliers, $ API Reference Price

10 API Suppliers
5 USDMF
2 EU WC
2 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 3 FDA Orange Book, 3 Europe, 1 Canada, 1 South Africa, 2 Listed Dossiers

10 FDF Dossiers
3 FDA Orange Book
3 Europe
1 Canada
1 South Africa
2 Listed Dossiers

DIGITAL CONTENT

8 NEWS #PharmaBuzz

8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices

1 US Medicaid Prescriptions
2 Finished Drug Prices

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

8 US Patents
3 Health Canada Patents

$ API Ref.Price (USD/KG) : 1,329,026 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Pfizer Canada Inc.

02 2Pfizer Canada ULC

filter Patent Reset all filters

3 All

01 12187024

02 12429020

03 12493878

filter Product Reset all filters

3 All

01 3Temsirolimus

filter Dosage Reset all filters

3 All

01 3Solution

filter Exp Date Reset all filters

3 All

01 12015-04-14

02 12021-11-13

03 12023-07-25

Product Main Page

01

Pfizer Canada Inc.

Temsirolimus

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-04-14

Date Granted : 2004-08-10

Temsirolimus

Brand Name : TORISEL

Patent Number : 2187024

Filing Date : 1995-04-14

Strength per Unit : 25mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2015-04-14

Date Granted : 2004-08-10

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Temsirolimus

BioAsia

Not Confirmed

Pfizer Canada ULC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-11-13

Date Granted : 2009-05-26

Temsirolimus

Brand Name : TORISEL

Patent Number : 2429020

Filing Date : 2001-11-13

Strength per Unit : 25mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2021-11-13

Date Granted : 2009-05-26

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Temsirolimus

BioAsia

Not Confirmed

Pfizer Canada ULC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-25

Date Granted : 2013-07-23

Temsirolimus

Brand Name : TORISEL

Patent Number : 2493878

Filing Date : 2003-07-25

Strength per Unit : 25mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2023-07-25

Date Granted : 2013-07-23

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!